Cancer Archives

Podcast 22 Sep 2023

Beyond Biotech podcast 64 – Precision immuno-oncology therapies

Despite the huge commercial success of PD-1 inhibitors and widespread use of checkpoint inhibitors such as anti-PD-1 or anti-CTLA4, 70 to 80% of patients still experience limited or no response to existing therapies. In response to this critical challenge, Portage Biotech is on a mission to expand the number of patients who derive long-term […]

September 22, 2023 - 2 minutesmins - By Jim Cornall

Best in Biotech 19 Sep 2023

Five biotech companies taking Los Angeles by storm

Known throughout history for being home to the iconic scene of Hollywood, in recent years Los Angeles has also become a thriving biotech hub, after years of playing second fiddle in the U.S. to the likes of South San Francisco and Boston. In this article, we take a look at five of the best Los […]

September 19, 2023 - 6 minutesmins - By Willow Shah-Neville

Podcast 15 Sep 2023

Beyond Biotech podcast 63 – Fighting cancer with STRIs

This week’s podcast is sponsored by Vetter. On this week’s episode, we have a conversation with Steve Worland, CEO of eFFECTOR Therapeutics. eFFECTOR is a clinical-stage biopharmaceutical company pioneering the development of a new class of cancer drugs referred to as STRIs (selective translation regulation inhibitors). eFFECTOR’s STRI product candidates target the eIF4F complex and […]

September 15, 2023 - 2 minutesmins - By Jim Cornall

Startup Scout 6 Sep 2023

Meet the startup developing novel cancer therapies from snake venom crotoxin

Snake venom is probably not the first thing that springs to mind when thinking about treatments or therapies, but the potential biotechnological and biomedical applications of animal venom components are actually widely recognized in scientific research. Now, Dublin-based startup Celtic Biotech is harnessing the potential of snake venom in an attempt to come up with […]

September 6, 2023 - 7 minutesmins - By Willow Shah-Neville

Best in Biotech 5 Sep 2023

Five recent advancements in ovarian cancer research over the past year

With around 7500 new cases reported in the U.K. alone every year, ovarian cancer may occur because of the inheritance of faulty genes like BRCA. Although the exact reason for cancer-causing genetic mutations is unknown – as with all other kinds of cancer – ovarian cancer research has shown that the risk increases with age, […]

September 5, 2023 - 9 minutesmins - By Roohi Mariam Peter

Podcast 1 Sep 2023

Beyond Biotech podcast 61 – Blood Cancer Awareness Month

On this week’s podcast, to recognize Blood Cancer Awareness Month, we have a conversation with Affimed’s CMO, Andreas Harstrick, to talk about blood cancers, and what Affimed is doing to tackle blood cancers. One of the main challenges in treating blood cancers is the limited options for therapeutic intervention. Treatment relies primarily on chemotherapy, which […]

September 1, 2023 - 2 minutesmins - By Jim Cornall

In Depth 31 Aug 2023

3D-printed tumors: startup hopes to drive cancer drug discovery

3D printing is capturing attention in the field of medicine of late. With the first 3D-printed drug being approved for the treatment of seizures, eight years ago, it was a consequential moment in healthcare, following which biotechs raced to step up personalized treatment. Now, with Chinese healthcare company Triastek turning heads after announcing promising clinical […]

August 31, 2023 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 30 Aug 2023

Five North Carolina biotech companies making their mark

North Carolina is home to Research Triangle Park, an R&D sanctuary situated between the cities of Raleigh and Durham, which just happens to be one of the biggest biotech hubs in the U.S., with a multitude of renowned companies. The southeastern state even rivals the likes of Boston, San Francisco, Los Angeles, and San Diego, […]

August 30, 2023 - 5 minutesmins - By Willow Shah-Neville

Podcast 25 Aug 2023

Beyond Biotech podcast 60 – The cost of research

On this week’s podcast, we have a conversation with Dr Jack Scannell, CEO of Etheros Pharmaceuticals Corp. Scannell recently co-authored a paper on the expenses related to clinical research and the factors that underly the translational failure of inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) in oncology. Costs and Causes of Oncology Drug Attrition […]

August 25, 2023 - 1 minutemin - By Jim Cornall

Podcast 18 Aug 2023

Beyond Biotech podcast 59 – World Lung Cancer Day

Since its inception in 2012, World Lung Cancer Day has been observed every year on August 1 in order to raise awareness of lung cancer issues and magnify the need for more lung cancer research funding. Around a quarter of a million people in the US alone will be diagnosed with some form of lung […]

August 18, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 17 Aug 2023

Six Toronto-based biotech companies to watch this year

The capital city of the Canadian province of Ontario, Toronto, is home to the Discovery District, a commercial hub that sees biotech and healthcare innovations and companies at its prime. Having witnessed the largest growth in tech jobs in North America between 2015 and 2020, Toronto, like Vancouver, is a significant contributor towards Canada’s life […]

August 17, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 9 Aug 2023

Meet the startup working to help treat a rare pediatric cancer

Nearly 50% of the children diagnosed with neuroblastoma are considered high-risk, where the tumor has spread, making surgery no longer a viable treatment option. Owing to this stark statistic, the disease is quite difficult to treat. But there might be light at the end of the tunnel. U.K.-based Renaissance Pharma’s drug candidate, which has shown […]

August 9, 2023 - 7 minutesmins - By Roohi Mariam Peter

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us